Glaucoma is one of the leading causes of irreversible blindness worldwide, yet many people do not notice its symptoms early. Experts say regular eye check-ups are the only way to detect the condition ...

A woman suffered "avoidable" sight loss after waiting two years for NHS cataract surgery in Wales. The woman endured 11 cancelled apppointments and failures in the management of her care during the ...

Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...

TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA provided statistically significant pain ...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in ...